Skip to content

Breath Ammonia Method for H. Pylori Detection: Phase II

Breath Ammonia Method for H. Pylori Detection: Phase II

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00194688
Enrollment
278
Registered
2005-09-19
Start date
2003-03-31
Completion date
2005-06-30
Last updated
2008-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter Infections

Keywords

ammonia

Brief summary

The objective is to evaluate the utility of a breath ammonia sensing device. In this study we will assess the effect of H. pylori infection on breath ammonia levels by measuring whether there is a change in the pattern or quantity of breath ammonia seen in H. pylori positive patients compared to H. pylori negative patients.

Detailed description

Healthy volunteers will undergo testing for H. pylori infection using a 14-C urea breath test, and the results will be compared to an experimental ammonia breath test. The breath sample will be collected by an investigational device that the patient will be exposed to consisting of a plastic mouth-piece which is attached to a T-tubing section having a side-arm port through which a fiberoptic ammonia sensor is inserted inside the tube. To meet the Phase II specific aim, the scope of the clinical trials is expanded addressing the following specific objectives: * Test refinements of the sensing system (hardware, software, & breath test device) * Determine whether a urea dose-response effect exists following urea ingestion, * Define the optimal cutoff values for expired breath ammonia to allow optimal discrimination of H. pylori infected vs. uninfected persons. * Determine the appropriate time interval for breath ammonia testing following urea ingestion. * Determine whether there is a change in breath ammonia level after H. pylori treatment.

Interventions

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
University of Washington
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult volunteers not meeting

Design outcomes

Primary

MeasureTime frame
Sensitivity and specificity of breath ammonia measurement for H. pylori infection

Secondary

MeasureTime frame
Determination of a dose response relationship for oral urea dose and breath ammonia level.
Determination of whether breath ammonia measurement allows determination of successful H. pylori treatment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026